Acyclovir

NDC 63323-325 · Fresenius Kabi USA, LLC

FDA carries 2 listing records for this NDC; the most recent is shown.

Generic nameacyclovir

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)ACYCLOVIR SODIUM

Strength50 mg/mL

Pharmacologic classDNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]

Marketing categoryANDA

Packages

63323-325-14 — 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-325-14) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-325-41)

63323-325-24 — 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-325-24) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-325-43)

63323-325-10 — 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-325-10) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-325-03)

63323-325-20 — 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-325-20) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-325-09)

Billed under HCPCS

J0133 — Injection, acyclovir, 5 mg Medicare Part B payment limit (ASP + 6%): $0.04

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0143-9657 — Acyclovir, 0143-9658 — Acyclovir, 55150-154 — Acyclovir Sodium, 55150-155 — Acyclovir Sodium, 65219-622 — ACYCLOVIR, 65219-624 — ACYCLOVIR, 68382-048 — ACYCLOVIR, 68382-049 — ACYCLOVIR, 70436-030 — acyclovir, 70771-1383 — ACYCLOVIR, 70771-1384 — ACYCLOVIR, 84549-155 — Acyclovir Sodium

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.